Karla A. Fenton

3.9k total citations
72 papers, 2.6k citations indexed

About

Karla A. Fenton is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Karla A. Fenton has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Infectious Diseases, 36 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Karla A. Fenton's work include Viral Infections and Outbreaks Research (52 papers), Viral Infections and Vectors (47 papers) and Hepatitis B Virus Studies (18 papers). Karla A. Fenton is often cited by papers focused on Viral Infections and Outbreaks Research (52 papers), Viral Infections and Vectors (47 papers) and Hepatitis B Virus Studies (18 papers). Karla A. Fenton collaborates with scholars based in United States, France and Mongolia. Karla A. Fenton's co-authors include Thomas W. Geisbert, Krystle N. Agans, Chad E. Mire, Robert W. Cross, Joan B. Geisbert, Viktoriya Borisevich, Daniel J. Deer, Abhishek N. Prasad, Courtney Woolsey and Christopher C. Broder and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Karla A. Fenton

69 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karla A. Fenton United States 31 2.1k 1.2k 355 337 198 72 2.6k
Robert W. Cross United States 29 2.0k 1.0× 1.1k 0.9× 300 0.8× 247 0.7× 211 1.1× 89 2.4k
Krystle N. Agans United States 32 2.1k 1.0× 1.3k 1.1× 488 1.4× 246 0.7× 218 1.1× 80 2.7k
Elaine Haddock United States 31 2.2k 1.1× 728 0.6× 224 0.6× 356 1.1× 179 0.9× 62 2.6k
Joseph Prescott United States 28 1.7k 0.8× 597 0.5× 126 0.4× 379 1.1× 136 0.7× 60 2.0k
Alan Schmaljohn United States 29 2.8k 1.3× 1.2k 0.9× 577 1.6× 428 1.3× 329 1.7× 38 3.6k
Valentina A. Volchkova France 30 2.7k 1.3× 1.4k 1.1× 364 1.0× 207 0.6× 279 1.4× 42 3.2k
Lisa Fernando Canada 22 2.1k 1.0× 1.3k 1.0× 271 0.8× 152 0.5× 364 1.8× 27 2.9k
Igor S. Lukashevich United States 30 2.6k 1.2× 1.1k 0.9× 323 0.9× 431 1.3× 326 1.6× 82 2.9k
Reed S. Shabman United States 28 1.8k 0.9× 601 0.5× 451 1.3× 924 2.7× 125 0.6× 42 2.5k
Joseph N. Fair United States 19 908 0.4× 785 0.6× 679 1.9× 357 1.1× 162 0.8× 30 1.9k

Countries citing papers authored by Karla A. Fenton

Since Specialization
Citations

This map shows the geographic impact of Karla A. Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla A. Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla A. Fenton more than expected).

Fields of papers citing papers by Karla A. Fenton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla A. Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla A. Fenton. The network helps show where Karla A. Fenton may publish in the future.

Co-authorship network of co-authors of Karla A. Fenton

This figure shows the co-authorship network connecting the top 25 collaborators of Karla A. Fenton. A scholar is included among the top collaborators of Karla A. Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla A. Fenton. Karla A. Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cross, Robert W., Jacquelyn Turcinovic, Abhishek N. Prasad, et al.. (2026). Oral 4′-fluorouridine rescues nonhuman primates from advanced Lassa fever. Nature. 650(8103). 961–969.
2.
Fenton, Karla A., et al.. (2025). Natural History of Chapare Virus Infection in Strain 13 Guinea Pigs. The Journal of Infectious Diseases. 231(5). e867–e872. 2 indexed citations
3.
Cross, Robert W., Courtney Woolsey, Abhishek N. Prasad, et al.. (2025). Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates. Nature Medicine. 31(4). 1303–1311. 5 indexed citations
4.
Prasad, Abhishek N., Courtney Woolsey, Viktoriya Borisevich, et al.. (2025). Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virus. Nature Communications. 16(1). 3824–3824. 1 indexed citations
5.
Halfmann, Peter, Viktoriya Borisevich, Corri B. Levine, et al.. (2023). The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets. The Journal of Infectious Diseases. 228(Supplement_7). S587–S593.
6.
Cross, Robert W., Karla A. Fenton, Stephanie L. Foster, Joan B. Geisbert, & Thomas W. Geisbert. (2023). Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence Between Angola and Ci67 Strains. The Journal of Infectious Diseases. 228(Supplement_7). S559–S570.
7.
Jayaprakash, Anitha D., Adam J. Ronk, Abhishek N. Prasad, et al.. (2023). Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats. Viruses. 15(2). 350–350. 8 indexed citations
8.
Cross, Robert W., Abhishek N. Prasad, Courtney Woolsey, et al.. (2023). Natural history of nonhuman primates after conjunctival exposure to Ebola virus. Scientific Reports. 13(1). 4175–4175. 10 indexed citations
9.
Cross, Robert W., Megan L. Heinrich, Karla A. Fenton, et al.. (2023). A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proceedings of the National Academy of Sciences. 120(34). e2304876120–e2304876120. 17 indexed citations
10.
Cross, Robert W., Courtney Woolsey, Abhishek N. Prasad, et al.. (2022). A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever. Cell Reports. 40(3). 111094–111094. 27 indexed citations
11.
Foster, Stephanie L., Courtney Woolsey, Viktoriya Borisevich, et al.. (2022). A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proceedings of the National Academy of Sciences. 119(12). e2200065119–e2200065119. 38 indexed citations
12.
Zeitlin, Larry, Robert W. Cross, Joan B. Geisbert, et al.. (2021). Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proceedings of the National Academy of Sciences. 118(11). 14 indexed citations
13.
Cross, Robert W., Zachary A. Bornholdt, Abhishek N. Prasad, et al.. (2021). Combination therapy protects macaques against advanced Marburg virus disease. Nature Communications. 12(1). 1891–1891. 56 indexed citations
14.
Mire, Chad E., Yee‐Peng Chan, Viktoriya Borisevich, et al.. (2019). A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. The Journal of Infectious Diseases. 221(Supplement_4). S471–S479. 49 indexed citations
15.
Mire, Chad E., Joan B. Geisbert, Viktoriya Borisevich, et al.. (2017). Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Science Translational Medicine. 9(384). 69 indexed citations
16.
Satterfield, Benjamin A., Robert W. Cross, Karla A. Fenton, et al.. (2016). Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets. Journal of Virology. 90(14). 6326–6343. 40 indexed citations
17.
Pawęska, Janusz T., Petrus Jansen van Vuren, Karla A. Fenton, et al.. (2015). Lack of Marburg Virus Transmission From Experimentally Infected to Susceptible In-Contact Egyptian Fruit Bats. The Journal of Infectious Diseases. 212(suppl 2). S109–S118. 53 indexed citations
18.
Thi, Emily P., Chad E. Mire, Amy C. H. Lee, et al.. (2015). Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature. 521(7552). 362–365. 190 indexed citations
19.
Cross, Robert W., Karla A. Fenton, Joan B. Geisbert, Chad E. Mire, & Thomas W. Geisbert. (2015). Modeling the Disease Course ofZaire ebolavirusInfection in the Outbred Guinea Pig. The Journal of Infectious Diseases. 212(suppl 2). S305–S315. 34 indexed citations
20.
Mire, Chad E., Robert W. Cross, Krystle N. Agans, et al.. (2013). Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virology Journal. 10(1). 353–353. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert W. Cross Breakdown of academic impact, for papers by Krystle N. Agans Breakdown of academic impact, for papers by Elaine Haddock Breakdown of academic impact, for papers by Joseph Prescott Breakdown of academic impact, for papers by Alan Schmaljohn Breakdown of academic impact, for papers by Valentina A. Volchkova Breakdown of academic impact, for papers by Lisa Fernando Breakdown of academic impact, for papers by Igor S. Lukashevich Breakdown of academic impact, for papers by Reed S. Shabman Breakdown of academic impact, for papers by Joseph N. Fair
Rankless by CCL
2026